PT99032A - Processo de preparacao de derivados do benzimidazolo e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de derivados do benzimidazolo e de composicoes farmaceuticas que os contem

Info

Publication number
PT99032A
PT99032A PT99032A PT9903291A PT99032A PT 99032 A PT99032 A PT 99032A PT 99032 A PT99032 A PT 99032A PT 9903291 A PT9903291 A PT 9903291A PT 99032 A PT99032 A PT 99032A
Authority
PT
Portugal
Prior art keywords
hydrogen
pharmaceutical compositions
compositions containing
preparation procedure
benzimidazole derivatives
Prior art date
Application number
PT99032A
Other languages
English (en)
Other versions
PT99032B (pt
Inventor
Frank Watjen
Soren-Peter Olesen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of PT99032A publication Critical patent/PT99032A/pt
Publication of PT99032B publication Critical patent/PT99032B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Graft Or Block Polymers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99032A 1990-09-24 1991-09-24 Processo de preparacao de derivados do benzimidazolo e de composicoes farmaceuticas que os contem PT99032B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58690090A 1990-09-24 1990-09-24

Publications (2)

Publication Number Publication Date
PT99032A true PT99032A (pt) 1993-11-30
PT99032B PT99032B (pt) 1999-02-26

Family

ID=24347548

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99032A PT99032B (pt) 1990-09-24 1991-09-24 Processo de preparacao de derivados do benzimidazolo e de composicoes farmaceuticas que os contem

Country Status (15)

Country Link
EP (1) EP0477819B1 (pt)
JP (1) JP3203017B2 (pt)
KR (1) KR100195770B1 (pt)
AT (1) ATE119887T1 (pt)
AU (1) AU635440B2 (pt)
CA (1) CA2052041C (pt)
DE (1) DE69108156T2 (pt)
DK (1) DK0477819T3 (pt)
ES (1) ES2072504T3 (pt)
FI (1) FI103408B1 (pt)
IE (1) IE67133B1 (pt)
NO (1) NO180795C (pt)
NZ (1) NZ239540A (pt)
PT (1) PT99032B (pt)
ZA (1) ZA916805B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520200B1 (en) * 1991-06-24 1998-02-18 Neurosearch A/S Imidazole compounds, their preparation and use
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5232899A (en) * 1992-06-08 1993-08-03 Imperial Chemical Industries Plc Benzoxazolinones and their use as herbicides
AU5433594A (en) * 1992-11-19 1994-06-08 Dainippon Pharmaceutical Co. Ltd. 3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DK28893D0 (da) * 1993-03-15 1993-03-15 Neurosearch As Benzimidazole derivater, deres fremstilling og anvendelse
DK41193D0 (da) * 1993-04-07 1993-04-07 Neurosearch As Ionkanalaabnere
US5637470A (en) * 1994-05-13 1997-06-10 Merck & Co., Inc. Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5565483A (en) * 1995-06-07 1996-10-15 Bristol-Myers Squibb Company 3-substituted oxindole derivatives as potassium channel modulators
TW504504B (en) * 1996-11-26 2002-10-01 Bristol Myers Squibb Co 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
US5893085A (en) * 1997-06-10 1999-04-06 Phillips; Ronald W. Dynamic fuzzy logic process for identifying objects in three-dimensional data
EP1011677A4 (en) * 1997-08-28 2002-03-20 Bristol Myers Squibb Co 4-ARYL-3-AMINOQUINOLEIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS
WO2000034248A1 (en) 1998-12-04 2000-06-15 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
NZ510987A (en) 1998-12-04 2004-02-27 Bristol Myers Squibb Co 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
JP2005533814A (ja) * 2002-06-26 2005-11-10 ポセイドン・ファーマスーティカルス・アクティーゼルスカブ 新規ベンズイミダゾール−２−オン誘導体及びその使用方法
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
ES2222831B2 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de principio activo que comprende un compuesto 2,5-dihidroxibencenosulfonico y un modulador de los canales de k+.
PE20060572A1 (es) * 2004-07-27 2006-06-27 Novartis Ag Compuestos de benzoimidazolona como inhibidores de hsp90
JP5313883B2 (ja) * 2007-04-18 2013-10-09 キッセイ薬品工業株式会社 含窒素縮合環誘導体、それを含有する医薬組成物及びその医薬用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH460028A (de) * 1965-01-22 1968-07-31 Wander Ag Dr A Verfahren zur Herstellung von Benzimidazolonderivaten
FR1561830A (pt) * 1968-05-08 1969-03-28
GB1408408A (en) * 1971-11-24 1975-10-01 Beecham Group Ltd Benzimidazole derivatives
GB1476949A (en) * 1974-11-20 1977-06-16 Wyeth John & Brother Ltd Imidazo-1,2-a-benzimidazole and pyrimido-1,2-a-benzimidazole derivatives their preparation and their pharmaceutical compositions
CH622009A5 (pt) * 1976-06-11 1981-03-13 Ciba Geigy Ag
DE3042481A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
ES2052544T3 (es) * 1986-02-03 1994-07-16 Janssen Pharmaceutica Nv Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas.

Also Published As

Publication number Publication date
EP0477819A3 (en) 1992-05-20
IE67133B1 (en) 1996-03-06
KR920006327A (ko) 1992-04-27
ES2072504T3 (es) 1995-07-16
FI914275A0 (fi) 1991-09-11
NO180795C (no) 1997-06-25
AU8276791A (en) 1992-03-26
NO913728L (no) 1992-03-25
NO180795B (no) 1997-03-17
NZ239540A (en) 1993-11-25
DK0477819T3 (da) 1995-07-17
DE69108156T2 (de) 1995-07-06
IE913197A1 (en) 1992-02-25
EP0477819A2 (en) 1992-04-01
ATE119887T1 (de) 1995-04-15
KR100195770B1 (ko) 1999-06-15
JPH04305568A (ja) 1992-10-28
ZA916805B (en) 1992-05-27
EP0477819B1 (en) 1995-03-15
PT99032B (pt) 1999-02-26
AU635440B2 (en) 1993-03-18
FI914275A (fi) 1992-03-25
CA2052041A1 (en) 1992-03-25
CA2052041C (en) 2002-08-20
FI103408B (fi) 1999-06-30
NO913728D0 (no) 1991-09-23
DE69108156D1 (de) 1995-04-20
JP3203017B2 (ja) 2001-08-27
FI103408B1 (fi) 1999-06-30

Similar Documents

Publication Publication Date Title
PT99032A (pt) Processo de preparacao de derivados do benzimidazolo e de composicoes farmaceuticas que os contem
BR9806296A (pt) Derivados de ácido sulfìnico e sua preparação e uso
YU20197A (sh) Analozi vitamina d3, farmaceutske kompozicije koje ih sadrže kao aktivnu materiju i njihova upotreba u proizvodnji farmaceutskih kompozicija
FI884955A (fi) Konserverade haor- och hudrengoeringsmedel och anvaendning av en konserveringsmedelkombination.
DK157061C (da) Fremgangsmaade til fremstilling af et heparinoid med antitrombotisk virkning
PT82512B (pt) Processo para a preparacao de derivados de quinolilglicinamidas com actividade psicotropica e de composicoes farmaceuticas que os contem
FI831388L (fi) 2-/2'-hydroxi-3'-(1,1-dimetylpropylamino)-propoxi/- -fenylpropionfenon, syreadditionssalter av denna foerfarande foer framstaellning av denna och farmaceutiska sammansaettningar
PT94078A (pt) Processo para a preparacao de derivados de acido butenoico e de composicoes farmaceuticas que os contem
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
FI941214A (fi) Bentsimidatsolin johdannaisia, niiden valmistus ja käyttö
ATE7224T1 (de) Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate.
PT78155A (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung
ES2038799T3 (es) Derivados de 3-ciano-4-fenil-pirrol.
ATE114307T1 (de) Phenylglycidamide, verwendbar in der herstellung von alpha-hydroxy-beta-sulfido-arylpropionsäure- derivaten.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19981111

TE3A Change of address (patent)

Owner name: NEUROSEARCH A/S

Effective date: 19990730

PC3A Transfer or assignment

Free format text: POSEIDON PHARMACEUTICALS A/S DK

Effective date: 20030506

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090511